Table 2.
Coronavirus disease 2019 symptoms at the first positive severe acute respiratory syndrome coronavirus 2 test
| Characteristics | Patients (n=46)a |
|---|---|
| Symptomatic before (or at) the first positive test | 43 (93.5%) |
| Among symptomatic (n=43): | |
| Gestational age at symptom onset, wk | 27.0 (21.0–33.9) |
| Number of symptoms reported | 2 (1–5) |
| Reported symptomsb: | |
| Cough | 30 (69.8%) |
| Subjective fever or chill | 22 (51.2%) |
| Nasal congestion | 21 (48.8%) |
| Shortness of breath or dyspnea | 19 (44.2%) |
| Headache | 14 (32.6%) |
| Loss of taste or smell | 13 (30.2%) |
| Myalgia | 13 (30.2%) |
| Fatigue | 12 (27.9%) |
| Sore throat | 12 (27.9%) |
| Other symptomc | 10 (23.3%) |
| Nausea or vomiting | 5 (11.6%) |
| Diarrhea | 3 (7.0%) |
| Days between symptom onset to resolutiond | 24 (13, 37) |
IQR, interquartile range; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Lokken et al. COVID-19 in pregnant women in Washington State. Am J Obstet Gynecol 2020.
Characteristics summarized as n (%) or median (IQR).
No significant difference (P<.05) by trimester of infection for any reported symptom. One patient had missing symptom data for the day of positive testing, but symptom data were available and included for a subsequent COVID-19-associated encounter.
Chest pain or tightness (n=5), dizziness (n=1), night sweats (n=1), tachycardia (n=1), epigastric pain (n=1), and right upper quadrant pain (n=1).
Estimated by generating a Kaplan–Meier curve to incorporate censoring. Pregnant patients with severe COVID-19 were non-Hispanic white (n=4), Hispanic race unknown (n=1), and race or ethnicity unknown (n=1).